Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis
- PMID: 7783054
Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis
Abstract
Objective: To compare levels of soluble tumor necrosis factor receptor (TNF-R) and soluble interleukin 2 receptor (sIL-2R) in sera and synovial fluids (SF) of patients with rheumatoid arthritis (RA), reactive arthritis (ReA), and osteoarthritis (OA) in order to investigate the usefulness of soluble cytokine receptors for differentiation diagnosis and their involvement in the pathophysiology of rheumatic diseases.
Methods: Soluble TNF-R (55 kDa), sIL-2R, and TNF-alpha were measured by ELISA in sera and SF of patients with RA, ReA, and OA and correlated with serological and clinical disease activity variables.
Results: Serum TNF-R was significantly (p < 0.0001) elevated in RA (4.6 +/- 2.1 ng/ml, mean +/- SD) compared to ReA (2.5 +/- 0.6 ng/ml), OA (2.2 +/- 0.7 ng/ml), and healthy controls (2.0 +/- 0.4 ng/ml). In SF mean TNF-R levels were 21 +/- 9.3 ng/ml in RA, 12.5 +/- 5.1 ng/ml in ReA, and 8.7 +/- 3.7 ng/ml in OA (p < 0.0001 for RA vs ReA or OA; p < 0.02 for ReA vs OA). SF levels were significantly higher in rheumatoid factor (RF) positive than in RF negative patients with RA. In patients with RA, correlations were found between TNF-R and TNF-alpha in SF (r = 0.32, p < 0.01), and between TNF-R and early morning stiffness (r = 0.4, p < 0.003 in serum; r = 0.29, p < 0.05 in SF). However, there was no correlation with disease activity variables such as Ritchie index, erythrocyte sedimentation rate (ESR) or C-reactive protein. Serum levels of IL-2R were elevated in RA and ReA, but a significant difference was found only for RA versus OA and controls (p < 0.0005), whereas in SF significant differences existed between all 3 patient groups (RA/ReA: p < 0.004; RA/OA: p < 0.0001; ReA/OA: p < 0.0003); both in serum and SF, levels of RF positive patients with RA were higher than those of RF negative patients. In patients with RA, IL-2R correlated weakly with ESR (r = 0.24, p < 0.05), iron concentration (r = -0.35, p < 0.005), and CRP (r = 0.24, p < 0.05).
Conclusion: In RA, in contrast to ReA and OA, TNF-R and IL-2R were not only elevated in the joint fluid but also in serum. This indicates general activation of the immune system in RA, but not in ReA and OA. Therefore the soluble receptors, especially TNF-R, might become useful diagnostic variables to distinguish RA from ReA and OA.
Comment in
-
Soluble tumor necrosis factor receptors in arthritis.J Rheumatol. 1995 Mar;22(3):382-4. J Rheumatol. 1995. PMID: 7783050 Review. No abstract available.
Similar articles
-
Upregulation of cytokine receptors sTNF-R55, sTNF-R75, and sIL-2R in psoriatic arthritis synovial fluid.J Rheumatol. 1998 Jan;25(1):105-10. J Rheumatol. 1998. PMID: 9458212
-
Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.Ital J Biochem. 2005 Sep-Dec;54(3-4):248-57. Ital J Biochem. 2005. PMID: 16688934
-
Soluble interleukin 6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies.J Rheumatol. 1997 Nov;24(11):2069-75. J Rheumatol. 1997. PMID: 9375862
-
Arthritic and non-arthritic synovial fluids modulate IL10 and IL1RA gene expression in differentially activated primary human monocytes.Osteoarthritis Cartilage. 2015 Nov;23(11):1853-7. doi: 10.1016/j.joca.2015.06.003. Osteoarthritis Cartilage. 2015. PMID: 26521731 Review.
-
Acute-phase proteins in osteoarthritis.Semin Arthritis Rheum. 1995 Oct;25(2):75-86. doi: 10.1016/s0049-0172(95)80020-4. Semin Arthritis Rheum. 1995. PMID: 8578314 Review.
Cited by
-
Effects of Antitumor Necrosis Factor Therapy on Osteoprotegerin, Neopterin, and sRANKL Concentrations in Patients with Rheumatoid Arthritis.Dis Markers. 2015;2015:276969. doi: 10.1155/2015/276969. Epub 2015 Oct 21. Dis Markers. 2015. PMID: 26576067 Free PMC article.
-
Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.Arthritis Res Ther. 2005;7(6):R1227-34. doi: 10.1186/ar1816. Epub 2005 Sep 7. Arthritis Res Ther. 2005. PMID: 16277675 Free PMC article.
-
Borrelia burgdorferi migrates into joint capsules and causes an up-regulation of interleukin-8 in synovial membranes of dogs experimentally infected with ticks.Infect Immun. 1997 Apr;65(4):1273-85. doi: 10.1128/iai.65.4.1273-1285.1997. Infect Immun. 1997. PMID: 9119462 Free PMC article.
-
Increased synovial fluid levels of soluble CD23 are associated with an erosive status in rheumatoid arthritis (RA).Clin Exp Immunol. 2000 Apr;120(1):194-9. doi: 10.1046/j.1365-2249.2000.01198.x. Clin Exp Immunol. 2000. PMID: 10759783 Free PMC article.
-
Interference of tumor necrosis factor inhibitor treatments on soluble tumor necrosis factor receptor 2 levels in rheumatoid arthritis.Pract Lab Med. 2019 May 3;16:e00122. doi: 10.1016/j.plabm.2019.e00122. eCollection 2019 Aug. Pract Lab Med. 2019. PMID: 31193412 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous